宫颈腺癌临床治疗与预后——附44例分析  

Analysis of Clinical Treatment and Prognosis for Cervical Adenocarcinoma

作　　者：周学惠[1] 

机构地区：[1]江苏省肿瘤防治研究所妇瘤科,江苏南京210009

出　　处：《肿瘤防治杂志》2001年第4期409-410,共2页China Journal of Cancer Prevention and Treatment

摘　　要：目的 :探讨宫颈腺癌合理的治疗方法及其影响预后的因素。方法 :对 1986～ 1995年 4 4例宫颈腺癌患者的临床资料进行回顾分析。结果 :5年总生存率 59 0 9% ,其中ⅠA 10 0 % ,ⅠB 50 % ,Ⅱ期72 72 % ,Ⅲ期 4 4 4 4 %。临床分期、局部肿瘤直径、肌层浸润和淋巴结转移对 5年生存率有影响。结论 :ⅠB期以上的宫颈腺癌应予以综合治疗 ;影响宫颈腺癌的预后因素包括临床病理分期、组织学类型及治疗方式等。Objectuve:To study the factors influencing clinical treatment and prognosis of cervical adenocarcinoma.Methods 44 cases underwent cervical adenocarcinoma from Jan,1986 to Sep,1995 were followed up and analysed.Results In 44 cases,the overall 5 year survial rate was 59 09%,while stage ⅠA 100%,ⅠB 50%,Ⅱ72 7%,Ⅲ44 44%.Clinical stage,local tumor volume,muscular invasion and lymph node metastasis have exerted effects on 5 year survial rate.Conclusions Cervical intraepithelial neoplasia and mico invasive adenocarcinoma must be paid attention to.Combination treatment including surgery,radiotherapy and themotherapy should be given for high risk cervical adenocarcinoma.

关 键 词：宫颈肿瘤 治疗 腺癌 预后 

分 类 号：R737.33[医药卫生—肿瘤]